Micro RNAs (miRNAs) play an important role during renal development and show a tissue-specific enrichment in the kidney. Nephroblastomas, embryonal renal neoplasms of childhood, are considered to develop from nephrogenic rests (NRs) and resemble morphologically and genetically developing kidney. We therefore investigated the role of kidney-enriched miRNAs in the pathogenesis of nephroblastomas. miR-192, miR-215 and miR-194 had a significantly lower expression in nephroblastomas regardless of the subtype compared with mature kidney measured by quantitative real-time-PCR. miR-141 and miR-200c showed a significantly lower expression in blastema-type and mixed-type tumors. In comparison with NRs, a significantly lower expression of miR-192, miR-194 and miR-215 was identified in blastematype, mixed-type and stroma-type nephroblastomas and of miR-141 and miR-200c in blastema-type tumors. Kidney parenchyma had a significantly higher expression of miR-192, miR-194, miR-215 and miR-200c compared with NRs. In this study, the activin receptor type 2B (ACVR2B), a member of the transforming growth factor (TGF)-b pathway, was identified as single common target gene for miR-192, miR-215, miR-194, miR-141 and miR200c in silico for the first time. The interaction between all five miRNAs and ACVR2B was also verified by an in vitro assay. Additionally, a distinct protein expression of ACVR2B was detected in 53 of 55 nephroblastomas paralleled by an upregulation of ACVR2B messenger RNA demonstrated in 25 nephroblastomas of all subtypes. A differential regulation of ACVR2B by miRNAs in NRs and nephroblastomas appears to be an important step in the pathogenesis of nephroblastomas implicating for the first time the TGF-b pathway in this process.
Introduction
Micro RNAs (miRNAs) are small non-coding fragments of RNA influencing the expression levels of messenger RNA (mRNA) by posttranscriptional mechanisms (1) . They bind to the 3#-untranslated region (UTR) of the respective target thereby leading to degradation of the RNA or suppression of protein translation (2, 3) . During kidney development, expression of miRNAs seems to play a role predominantly in later stages. In terminally differentiated epithelia, several miRNAs can be detected. The miR-200 family has been described to be involved in the process of mesenchymal-epithelial transition during renal development (4) . In an animal model, the enzyme responsible for maturation of miRNAs, Dicer, was specifically suppressed in podocytes. At 3 weeks of age, the transgenic animals showed proteinuria and end-stage kidney disease (5) . In an additional animal model with deletion of Dicer in podocytes, mmu-miR23b, mmu-miR24 and mmu-miR26b were identified to be responsible for glomerular filtration (6) . Recently, four patients carrying mutations of DICER1 have been identified with nephroblastomas (7, 8) .
Nephroblastomas are intriguing embryonal malignant renal neoplasms of childhood. Not only their morphology but also their genetic changes resemble developing kidney (9, 10) . They consist of three different types of tissue comprising blastema, mesenchyme and epithelial tissue. Blastema usually presents as solid sheets of cells with large nuclei, epithelial structures often consist of immature tubules or immature glomeruloid bodies. The mesenchymal tissue represents immature embryonal mesenchyme but can also show higher differentiated structures, such as adipose tissue, skeletal muscle or hyaline cartilage (9) . Nephroblastomas are assumed to originate from nephrogenic rests (NRs). NRs are abnormal remnants of metanephric embryonal tissue persisting beyond 36 weeks of gestation. Incidental NRs can be found in $1% of children without renal tumors and in 30-44% of kidneys containing nephroblastomas (11) . Identification of incidental NRs in resected nephroblastoma specimens is very important, as NRs have been associated with bilateral and metachronous contralateral nephroblastomas (12, 13) . Several miRNAs have been identified to be deregulated in nephroblastomas, some of them targeting genes, which play a role during renal development. In a small number of sporadic nephroblastomas, deletions at chromosome 2q37.1 in conjunction with a decreased expression of miR-562, located in the genomic region that targets EYA1, were identified (14) . An overexpression of miR-483-3p was demonstrated and correlated with an increased level of IGF2 (insulin growth factor 2). Subsequently, this miRNA was shown to protect cells from apoptosis in in vitro and in vivo systems (15) . miR-185 also acts as tumor suppressor by repressing Six1. Samples of ovarian cancers and nephroblastomas exhibited a significantly reduced expression of miR-185 (16) .
Expression analysis of miRNAs in various tissues demonstrated a distinct expression of miR-192, miR-194, miR-204, miR-215 and miR-216 in mature kidney (17) . Another study performing tissue profiling demonstrated an enrichment of a set of miRNAs in the kidney, including miR-10a/b, miR-200a, miR-196a/b and miR-335 (18) .
To identify a potential common mechanism, we performed an in silico analysis, which identified for the first time three of the above mentioned miRNAs, miR-192, miR-194 as well as miR-215 and two additional miRNAs, miR-200c and miR-141 to target the same gene, the activin receptor type 2B (ACVR2B). This receptor plays a crucial role in the activation of activin, which is an important part of the transforming growth factor (TGF)-b signaling pathway (19) . Interestingly, members of the TGF-b superfamily play a fundamental role during renal development. Branching of the ureteric bud is controlled by various transcription factors (20) , among them activin A. The activity of activin is regulated by dimerization of two different receptors, activin receptor type I and II, which are part of the TGF-b signaling pathway (21, 22) . The type II receptor binds activin and in turn phosphorylates and activates the type I receptor, followed by a downstream activation of Smads (22) . mRNA expression of activin receptor type II was found in embryonal and adult kidneys of rats, protein expression was shown in the ureteric bud and the metanephric mesenchyme at E13 and E16. In an in vitro system of cultured metanephros, a truncated form of ACVR2B induced an increased branching of the ureteric bud and an increase of proliferation, whereas at the same time the proliferation in the metanephric mesenchyme decreased (23) . In adult mature kidneys, the activin receptor type II can be found only in tubular cells of the proximal and distal tubules and the collecting ducts (24) . Consequently, we hypothesized that activation of the TGF-b pathway through upregulation of the ACVR2B receptor via downregulation of miRNAs might play a role in the development of nephroblastomas. Therefore, we evaluated ACVR2B as a new potential target gene of miR-192, miR-194, miR215, miR-200c and miR-141 and their expression in nephroblastoma.
Materials and methods

Tissue samples
All tumors were obtained from the Kiel Paediatric Tumor Registry at the Department of Paediatric Pathology, University of Kiel, Germany. Tissue samples had been fixed in buffered formaldehyde and embedded in paraffin wax. Three micrometer sections of the samples were obtained for further analysis.
miRNA target prediction Different web servers of DIANA lab were used to predict the target genes and their target regions. A common target gene for the miRNAs analyzed in the TGF b pathway was identified by the DIANA-mirPath programme, which is a tool to identify molecular pathways targeted by single or multiple miRNAs (25) . DIANA-mirPath programme based on DIANA-micro-T-4.0 (beta version) was used to identify biological pathways targeted by miR-192, miR-194, miR-215, miR-141 and miR-200c (http://diana.cslab.ece.ntua.gr/pathways/). Computer mouse over option was used to demarcate a common target gene for all five miRNAs in possible targeted biological pathways predicted by the programme according to Àln P values. The identification of target regions of miR-192, miR-194, miR-215, miR141 and miR200c in the 3#-UTR region of the common target gene was performed by the DIANA-micro-T-3.0 (http://diana.cslab.ece.ntua.gr/ gr/microT/) program. All targeting regions of the miRNAs analyzed in the 3#-UTR of the ACVR2B gene (see Table I ) were identified by DIANA-microT 3.0 (26).
Cell lines
WT-CLS1 cells (Cell lines services, Heidelberg, Germany), an epithelial nephroblastoma cell line, were cultured in Isocoves medium (Sigma Aldrich, St Louis, MO) supplemented with 15% fetal bovine serum (PAA, Pasching, Austria), 1% penicillin and streptomycin (PAA) and 2 mM L-Glutamine (PAA). HEK293 cells (American type culture collection, Manassas, VA), an embryonic kidney cell line, were cultured in Dulbecco's Modified Eagle Medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (PAA), 1% penicillin and streptomycin (PAA) and 2mM L-Glutamine (PAA). Both cell lines were cultured at 37°C in a humidified atmosphere with 5% CO 2 .
mRNA and miRNA isolation Total cellular RNA from formalin-fixed paraffin-embedded samples was isolated using the RNAeasy FFPE kit (Qiagen, Hilden, Germany) and from cultured cells by TRIZOL (Invitrogen) according to the manufacturer's instructions.
miRNA quantitative real-time-PCR Expressions of mature miR-192, miR-194, miR-215, miR-141 and miR-200c were analyzed using the TaqMan miRNA Assay (Applied Biosystems, Carlsbad, CA). Expression of RNU6B (Applied Biosystems) was used as endogenous control. All measurements were performed in triplicate and relative expressions were calculated as DDCT.
mRNA quantitative real-time-PCR
Up to 500 ng of total RNA were reverse transcribed into complementary DNA using the High Capacity complementary DNA reverse transcription kit (Applied Biosystems) according to the manufacturer's instructions. Quantitative real-time-PCR was performed in triplicates with primers specific for ACVR2B and 18s RNA (Supplementary material, available at Carcinogenesis Online). Quantitative real-time-PCR was carried out on a 7900T Fast real-time PCR system (Applied Biosystems) using SYBR green as the detection fluorophore. 18s RNA was used as the internal control and relative gene expression levels were calculated as DDCT.
Immunohistochemistry ACVR2B (Abnova, Taipei City, Taiwan) antibodies were diluted 1:25 in antibody diluent (Dako, Glostrup, Denmark). The immunohistochemical staining procedure was performed using the automated VENTANA staining system (Ventana, Tucson, AZ).
Transfections of miRNA precursor molecules with the target regions and luciferase reporter assay WT-CLS1 cells were grown in six-well plates up to 50% confluence. Luciferase plasmid constructs were created by ligating oligonucleotides containing the target sites of the ACVR2B 3#-UTR downstream of the luciferase gene in the pMIR-REPORT TM Reporter Luciferase vector (Ambion, Carlsbad, CA) (Supplementary material, available at Carcinogenesis Online). Transfection was performed with a solution consisting of 2 lg firefly luciferase reporter vector containing the target sequence, 500 ng of pMIR-REPORT TM beta-gal control vector (Ambion) and pre-miRNA precursor molecules of miR-192, miR-194, miR-215, miR-141, miR-200c (Ambion) or pre-miR scrambled miRNA (Ambion). Pre-miRNA molecules were used at a final concentration of 100 nM and mixed with 12 ll lipofectamine 2000 (Invitrogen). A final volume of 100 ll was achieved by adding Opti-MEMÒ I reduced-serum medium (Invitrogen) per well. The transfection solution was incubated at 37°C for 30 min. Then, the mixture was added to 900 ll of serum-free medium covering the cells and 4 h after transfection, another 1 ml of medium containing serum was added. The medium was changed to standard growth medium after washing the cells with phosphate-buffered saline 24 h after the transfection.
Luciferase activity was measured 50 h after transfection (Bright Glo Luciferase Assay System; Promega, Madison, WI) using b-galactosidase for normalization (b-galactosidase Enzyme Assay System; Promega). Changes in the luciferase activity were calculated by dividing the luciferase activity of the test miRNA by the luciferase activity of the scrambled miRNA.
Western blot analysis HEK293 cells were grown in six-well plates up to 70% confluence and transfected with 100 nM pre-miRNA precursor molecules of miR-192, miR-194, miR-215, miR-141, miR-200c (Ambion) or pre-miR scrambled miRNA (Ambion). Transfections were performed as described above. Total cellular proteins were isolated 60 h after transfection by resuspending the cell pellets in RIPA buffer (Thermo Scientific, Rockford, IL) containing 1Â protease inhibitors (Halt protease and phosphatase inhibitor cocktail; Thermo Scientific). After keeping the samples on ice for 15 min, cells were sonicated and extracts were cleared by centrifugation for 10 min at 13 000 r.p.m. Supernatants were transferred into fresh tubes and protein concentrations were measured by the Lowry protein assay.
Thirty micrograms of proteins were loaded onto a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 1.5 mm gels for electrophoresis. Then, the proteins were transferred electrophoretically to a nitrocellulose membrane at 240 mA for 120 min. The membrane was blocked with 5% (vol/vol) skimmed milk powder (Bio-Rad, Hercules, CA) in TBST [0.2mM Tris, 15 mM NaCl, pH 7.4, 0.2% (vol/vol) Tween 20] for 1 h at room temperature. For immunodetection, the membrane was incubated with antibodies against ACVR2B (Abnova) diluted 1:100 in 1% (vol/vol) skimmed milk powder with TBST for 12 h at room temperature. Afterward, the membrane was washed in TBST three times for 5 min each at room temperature before treating the membrane with horseradish peroxidase conjugated anti-rabbit secondary antibody (Dako). The membrane was developed by exposure to a photosensitive film using Pierce ECl western blotting substrate (Thermo scientific). For normalization of the protein content, the membranes were stripped using stripping buffer (Bio-Rad) and washed in TBST three times for 5 min each at room temperature. The membranes were blocked as described above and incubated with antibodies against glyceraldehyde 3-phosphate dehydrogenase diluted 1:500 in 1% (vol/vol) skimmed milk powder with TBST and incubated overnight at 4°C. Detection was carried out as described above. Densitometric analysis was performed to quantify protein expression using ImageJ application.
Statistical analysis
All data were analyzed using Graphpad Prism softwareV5 (Graph pad, San Diego, CA). Statistical analysis for the comparison of the expression of miR-NA and mRNA was calculated by the Mann-Whitney test (non-parametric analysis) and the difference in the change of luciferase activity and protein content analyzed using western blot by the Student's t-test (parametric analysis), whereby P , 0.05 was considered as significant (27) . Expression of miR-141 was significantly higher in NRs compared with blastema-type nephroblastomas but did not differ significantly compared with epithelial-type, mixed-type, stroma-type nephroblastomas or mature kidney. Only one NR had a very high expression of miR-141 and miR-200c in comparison with all other NRs (Figure 1) .
Interestingly, miR-200c had a significantly lower expression in NRs compared with mature kidney and a significantly higher expression in relation to blastema-type nephroblastomas. In contrast, the expression of miR200c did not differ significantly between NRs and the other subtypes of nephroblastomas (see Figure 1 ).
All five miRNAs are targeting the ACVR2B gene, which is part of the TGF-b pathway according to an in silico analysis A web-based computational tool, Diana web path software, was used to predict target genes in the TGF-b pathway (25, 26) . Names of the five miRNAs were included as input in the DIANA-miRPath analysis based on DIANA-micro-T-4.0 (b-version). This web-based computational programme performs enrichment analysis of data sets with all available pathways provided by the Kyoto Encyclopedia of Genes (28) . Interactions of genes in biological pathways are diagrammatically represented in the KEGG database. The enrichment analysis of the input miRNAs regarding pathways is performed by a Pearson's chi-square test (25) . The combinatorial effect of the five miRNAs (Union data set) on the TGF-b pathway was 9.17 (Àln P value). Computer mouse over option displayed that miR-192, miR-194, miR-215, miR-141 and miR-200c are targeting a common gene ACVR2B. The analysis of other pathways, which had Àln P value of .9.17, did not show a common target gene for all five miRNAs (see Table I ).
mRNA and protein expression of ACVR2B are upregulated in most nephroblastomas compared with normal kidney Samples of 25 nephroblastomas including 4 blastema-type, 4 epithelialtype, 3 stroma-type, 13 mixed-type and 1 regressive nephroblastoma as well as 6 samples of mature kidney were analyzed for mRNA expression of ACVR2B. Compared with mature renal parenchyma, nephroblastomas had a significantly higher (P , 0.0013) mRNA expression ( Figure 2 ).
Membrane and cytoplasmic protein expression for ACVR2B was assessed immunohistochemically in 55 tumors, comprising 20 mixedtype, 4 epithelial-type, 4 blastema-type, 6 stroma-type and 21 regressive nephroblastomas. Additionally, protein expression of six incidentally detected NRs was analyzed. Corresponding nephroblastomas of the NRs were two regressive, three mixed-type and one stroma-type nephroblastoma.
The staining pattern of ACVR2B was assessed in all the different morphological components of nephroblastomas. Importantly, ACVR2B protein expression was detected in the main morphological components of nephroblastomas, in all blastemal areas, regardless of the subtype ( Figure 3A) , and in all tubular structures ( Figure 3B ) with the exception of one mixed nephroblastoma, which showed negative tubular structures, but positivity in the blastema. Undifferentiated mesenchyme showed negativity in 19 and positivity in 9 cases. A minority of nephroblastomas also contained some more specialized structures. These included immature glomeruloid bodies with expression of ACVR2B in three of five cases and skeletal muscle with expression of ACVR2B in four of six cases. Two mixed nephroblastomas were entirely negative in all tumor components.
A direct comparison between staining intensity of the tumor and the adjacent parenchyma was possible in 25 cases. Twenty-one tumors had a stronger protein expression of ACVR2B compared with adjacent normal kidney, two had a lower and one regressive and one mixed nephroblastoma the same intensity. In all other samples, a direct comparison with non-tumoral renal parenchyma was not possible, as sections contained exclusively areas of tumor. Correlation of mRNA and protein expression levels showed that the tumors with high mRNA expression of ACVR2B also had a strong protein expression.
All six NRs were positive for ACVR2B (Figure 3) . A direct comparison on the same section with corresponding nephroblastomas was possible in two cases, with corresponding nephroblastomas and normal kidney parenchyma in one case and with normal parenchyma in three cases. In all cases, NRs showed a higher expression than the corresponding normal parenchyma and a lower expression in comparison with the corresponding nephroblastomas. The miR-192 precursor co-transfected with target regions 2582-2610, 8021-8049 and 9188-9216, respectively, led to a significant decrease in luciferase activity compared with scrambled control (Figure 4 A-C) . Similarly, the 2582-2610 and 9188-9216 target regions of miR-215 showed a significant downregulation of the luciferase activity following the transfection of the miR-215 precursor ( Figure 4D and E) . 5 4) , blastema-type (n 5 6), mixed-type (n 5 11), stroma-type (n 5 3) nephroblastomas, NRs (n 5 9) and mature kidney parenchyma (n 5 7). miR-192, miR-194 and miR-215 have a significantly lower expression in all nephroblastoma subtypes compared with mature renal parenchyma. miR-141 and miR-200c have a significantly lower expression in blastema-type and mixed-type tumors compared with mature kidney. There is no significant difference between the other subtypes and kidney parenchyma (6 ¼P , 0.05, 6 ¼6 ¼P , 0.01, 6 ¼6 ¼6 ¼P , 0.001 versus mature renal tissue). Blastema-type, mixed-type and stroma-type nephroblastomas had a significantly lower expression of miR-192, miR-194 and miR-215 compared with NRs. miR-141 and miR-200c expressions were significantly lower in blastema-type tumors compared with NRs. Kidney parenchyma showed a significantly higher expression of miR-192, miR-194, miR-215 and miR-200c compared with NRs ( Ã P , 0.05, ÃÃ P , 0.01, ÃÃÃ P , 0.001 versus NRs, vertical bars represent þSEM).
miRNAs and their target ACVR2B in nephroblastomas
Out of the two target regions of miR-194, only 9328-9356 showed a downregulation of luciferase activity compared with scrambled control (Figure 4F and G) .
The target regions of miR-200c, 5632-5660 and 7567-7593, showed a significant downregulation following transfection with miR-200c precursors ( Figure 4H and I) .
miR-141 had a single target region 1872-1900, which showed a significant downregulation of luciferase activity compared with control ( Figure 4J) . Additionally, the regulation of protein expression by all miRNAs was investigated in HEK293 cells showing a high level of ACVR2B expression. Western blot analysis was performed in triplicates after transfecting pre-miRNAs and pre-scrambled control miRNA. A statistically significant downregulation of the protein expression of ACVR2B by miR-141 (P 5 0.0039), miR-200c (P 5 0.0028), miR-215 (P 5 0.0038), miR-194 (P 5 0.0054) and miR-192 (P 5 0.04) compared with scrambled control was identified by densitometric analysis ( Figure 5 ).
Discussion
miRNAs are involved in a wide variety of biological cellular functions including differentiation, proliferation and apoptosis (29, 30) . In addition, aberrant expression of miRNAs plays a role in the pathogenesis, progression and metastasis of malignant tumors. miRNAs can function as oncogenes or tumor suppressors and might even represent targets for therapeutical approaches (30) (31) (32) (33) (34) (35) (36) .
In our study, we demonstrate a downregulation of miR-192, miR-194 and miR-215 in all nephroblastomas regardless of the subtype. A controversial role of these miRNAs has already been discussed in other malignant tumor entities. Expression levels of miR-192 were found to be significantly reduced in adenocarcinomas in a rat model (37) . miR-192, miR-194 and mi-R-215 were also shown to be decreased in colon cancer samples in comparison with normal colon (38) . In contrast, high levels of miR-194 were detected in Barrett's epithelium and adenocarcinoma in comparison with normal gastric and oesophageal mucosa (39) .
We also show that miR-200c and miR-141 are downregulated in the majority of nephroblastomas with the exception of stroma-type nephroblastomas and one epithelial-type tumor consisting of mature tubules, which showed expression comparable with mature kidney parenchyma. Large international studies have revealed that stromatype and highly differentiated epithelial-type nephroblastomas characteristically have a very good outcome (40) , which might also be reflected by a distinct gene expression pattern since epithelial-type nephroblastomas with differentiated tubular growth pattern harbored a gene expression pattern analogous to an arrest following mesenchymal to epithelial transition (41) . The role of miR-141 and miR-200c has also been investigated in several other tumor entities. Comparison of gastric cancer cell lines, gastric cancer samples and adjacent non-neoplastic tissue revealed a significantly reduced expression of miR-141 in most of the neoplastic samples (42) . A comparison of clear cell renal carcinomas with corresponding non-malignant samples showed a decreased expression of miR-200c and miR-141. A comparison of the miRNA expression profiles also enabled a clear distinction between malignant and normal tissue according to the miRNA profile (34, (43) (44) (45) (46) . Differences in expression levels of several miRNAs including miR-200c were also able to discriminate between oncocytoma and chromophobe carcinoma in up to 93% (47) . In contrast, in a different study, high levels of miR-141 and miR-200c were found in renal clear cell carcinomas compared with normal renal tissue (48) . A comparison of ovarian cancer and normal tissue revealed overexpression of numerous miRNAs including miR-200c and miR-141 (49) .
The divergent results of expression of these miRNAs in different studies and tumor entities might also be related to the wide range of different functions and targets of miRNAs. Our in silico analysis demonstrated that all five miRNAs with low expression in the large majority of the nephroblastomas investigated target the same gene, ACVR2B, which has not been identified as a target gene of these Fig. 3 . Protein expression of ACVR2B was assessed by immunohistochemistry in various nephroblastoma subtypes (n 5 55). Blastemal regions, epithelial regions, mesenchyme (mixed type tumor-A, mixed type-B, Â400) and NRs (C, Â400) showed an intense membranous and cytoplasmic staining for ACVR2B compared with corresponding mature renal parenchyma. 
miRNAs and their target ACVR2B in nephroblastomas
Activins are part of the TGF-b pathway and act on cell growth and differentiation in different biological functions. The activity of activin is regulated by dimerization of two different receptors, activin receptor type I and II (21) . Activation of the TGF-b pathway plays a pivotal role in human tumorigenesis, acting as tumor suppressor or oncogene (22, (51) (52) (53) . The role of ACVR2B in different malignant neoplasms is controversial and might influence the role of the TGF-b pathway during tumorigenesis. ACVR2B showed a lower expression in colorectal carcinomas compared with normal epithelia. In addition, antibodies against ACVR2B were more abundant in normal sera compared with patients suffering from colorectal carcinoma (54). ACVR2B was also higher expressed in a well differentiated endometrial adenocarcinoma cell line than in a cell line derived from a poorly differentiated endometrial adenocarcinoma (55) . In a breast carcinoma cell-line, estradiol induced mitosis at the same time decreasing the expression of ACVR2B (56) . In contrast, the ovarian cancer cell line OVCAR-3 demonstrated a higher expression of ACVR2B compared with normal ovarian surface epithelium and showed proliferative induction by activin (57) . A distinct expression of ACVR2B was identified in 4 of 10 clear cell adenocarcinomas of the ovary (58) . Although the sample size in this study is rather low, it is interesting to note that the expression of ACVR2B is not only found in ovarian cancer cell lines but also in tumor samples. According to our analysis, nephroblastomas are by far the most homogenous group of neoplasms with regard to ACVR2B overexpression indicating an important pathogenetic role in the tumorigenesis of this neoplasm.
NRs are considered to be precursor lesions of nephroblastomas (11). However, genetic evidence for this assumption has so far been sparse (59) . We show that miRNAs and their target gene ACVR2B exhibit an expression level in between nephroblastomas and mature renal parenchyma. Typically, precursor lesions of malignant tumors harbor some but not all genetic lesions identified in the tumors, such as atypical adenomatous hyperplasia of the prostate and prostate adenocarcinoma (60) or the adenoma to carcinoma sequence of the colon (61) .
In our study, we demonstrate an important role of ACVR2B expression and the TGF-ß pathway in the tumorigenesis of nephroblastomas. Additionally, we verify the regulation of ACVR2B by five different miRNAs emphasizing an important role of microRNAs and the TGF-ß pathway in the pathogenesis of nephroblastomas at the same time.
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